Loading...
•
Jun 30, 2023
Conmed Q2 2023 Earnings Report
Conmed's second quarter results for 2023 showed growth in both Orthopedics and General Surgery.
Key Takeaways
CONMED Corporation reported strong growth in both Orthopedics and General Surgery for the second quarter of 2023. The company is raising its revenue guidance for the full year 2023 and now expects revenue between $1.230 billion and $1.260 billion. The Company now expects full-year 2023 adjusted diluted net earnings per share in the range of $3.40 to $3.55.
Excellent growth in both Orthopedics and General Surgery.
Built on the momentum generated during the first three months of the year.
Confident in ability to grow above market.
Continue to deliver clinical innovation to customers.
Forward Guidance
CONMED is raising its revenue guidance for the full year 2023 and now expects revenue between $1.230 billion and $1.260 billion, compared to its prior guidance of between $1.205 billion and $1.250 billion. The Company now expects full-year 2023 adjusted diluted net earnings per share in the range of $3.40 to $3.55, compared to its prior range of $3.30 to $3.50.
Positive Outlook
- Revenue guidance raised for full year 2023.
- Revenue now expected between $1.230 billion and $1.260 billion.
- Prior revenue guidance was between $1.205 billion and $1.250 billion.
- Full-year 2023 adjusted diluted net earnings per share expected in the range of $3.40 to $3.55.
- Prior range for adjusted diluted net earnings per share was $3.30 to $3.50.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...